Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · Real-Time Price · USD
8.94
+0.58 (6.87%)
At close: Nov 20, 2024, 4:00 PM
8.99
+0.05 (0.56%)
Pre-market: Nov 21, 2024, 6:37 AM EST

Sensus Healthcare Statistics

Total Valuation

SRTS has a market cap or net worth of $146.52 million. The enterprise value is $124.61 million.

Market Cap 146.52M
Enterprise Value 124.61M

Important Dates

The last earnings date was Thursday, November 14, 2024.

Earnings Date Nov 14, 2024
Ex-Dividend Date n/a

Share Statistics

SRTS has 16.39 million shares outstanding. The number of shares has increased by 0.16% in one year.

Current Share Class 16.39M
Shares Outstanding 16.39M
Shares Change (YoY) +0.16%
Shares Change (QoQ) +0.08%
Owned by Insiders (%) 19.01%
Owned by Institutions (%) 24.16%
Float 12.93M

Valuation Ratios

The trailing PE ratio is 15.71 and the forward PE ratio is 17.64.

PE Ratio 15.71
Forward PE 17.64
PS Ratio 3.53
Forward PS 3.75
PB Ratio 2.71
P/TBV Ratio 2.71
P/FCF Ratio 70.07
P/OCF Ratio 55.00
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.25, with an EV/FCF ratio of 59.59.

EV / Earnings 13.38
EV / Sales 3.02
EV / EBITDA 10.25
EV / EBIT 10.44
EV / FCF 59.59

Financial Position

The company has a current ratio of 10.52, with a Debt / Equity ratio of 0.01.

Current Ratio 10.52
Quick Ratio 7.59
Debt / Equity 0.01
Debt / EBITDA 0.05
Debt / FCF 0.31
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is 18.86% and return on invested capital (ROIC) is 14.90%.

Return on Equity (ROE) 18.86%
Return on Assets (ROA) 13.52%
Return on Capital (ROIC) 14.90%
Revenue Per Employee $1.18M
Profits Per Employee $266,029
Employee Count 35
Asset Turnover 0.75
Inventory Turnover 1.05

Taxes

In the past 12 months, SRTS has paid $3.56 million in taxes.

Income Tax 3.56M
Effective Tax Rate 27.66%

Stock Price Statistics

The stock price has increased by +317.76% in the last 52 weeks. The beta is 1.04, so SRTS's price volatility has been similar to the market average.

Beta (5Y) 1.04
52-Week Price Change +317.76%
50-Day Moving Average 6.53
200-Day Moving Average 5.38
Relative Strength Index (RSI) 77.13
Average Volume (20 Days) 238,544

Short Selling Information

The latest short interest is 535,646, so 3.27% of the outstanding shares have been sold short.

Short Interest 535,646
Short Previous Month 585,779
Short % of Shares Out 3.27%
Short % of Float 4.14%
Short Ratio (days to cover) 6.14

Income Statement

In the last 12 months, SRTS had revenue of $41.31 million and earned $9.31 million in profits. Earnings per share was $0.57.

Revenue 41.31M
Gross Profit 25.16M
Operating Income 11.94M
Pretax Income 6.45M
Net Income 9.31M
EBITDA 12.15M
EBIT 11.94M
Earnings Per Share (EPS) $0.57
Full Income Statement

Balance Sheet

The company has $22.56 million in cash and $651,000 in debt, giving a net cash position of $21.91 million or $1.34 per share.

Cash & Cash Equivalents 22.56M
Total Debt 651,000
Net Cash 21.91M
Net Cash Per Share $1.34
Equity (Book Value) 54.13M
Book Value Per Share 3.30
Working Capital 49.60M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $2.66 million and capital expenditures -$573,000, giving a free cash flow of $2.09 million.

Operating Cash Flow 2.66M
Capital Expenditures -573,000
Free Cash Flow 2.09M
FCF Per Share $0.13
Full Cash Flow Statement

Margins

Gross margin is 60.90%, with operating and profit margins of 28.91% and 22.54%.

Gross Margin 60.90%
Operating Margin 28.91%
Pretax Margin 31.16%
Profit Margin 22.54%
EBITDA Margin 29.42%
EBIT Margin 28.91%
FCF Margin -14.42%

Dividends & Yields

SRTS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.16%
Shareholder Yield -0.16%
Earnings Yield 6.35%
FCF Yield 1.43%

Analyst Forecast

The average price target for SRTS is $12.50, which is 39.82% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.50
Price Target Difference 39.82%
Analyst Consensus Strong Buy
Analyst Count 2
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 6